Assessment of Faecal Microbiota Transplant Stability in Deep-Freeze Conditions: A 12-Month Ex Vivo Viability Analysis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F24%3A43926888" target="_blank" >RIV/00064173:_____/24:43926888 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11120/24:43926888
Výsledek na webu
<a href="https://doi.org/10.1002/jcla.25023" target="_blank" >https://doi.org/10.1002/jcla.25023</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jcla.25023" target="_blank" >10.1002/jcla.25023</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Assessment of Faecal Microbiota Transplant Stability in Deep-Freeze Conditions: A 12-Month Ex Vivo Viability Analysis
Popis výsledku v původním jazyce
Background: Faecal microbiota transplantation (FMT) is an established treatment for Clostridioides difficile infection and is under investigation for other conditions. The availability of suitable donors and the logistics of fresh stool preparation present challenges, making frozen, biobanked stools an attractive alternative. Aims: This study aimed to evaluate the long-term viability of bacterial populations in faecal samples stored at -80oC for up to 12 months, supporting the feasibility of using frozen grafts for FMT. Methods: Fifteen faecal samples from nine healthy donors were processed, mixed with cryoprotectants and stored at -80oC. Samples were assessed at baseline and after 3, 6 and 12 months using quantitative culturing methods to determine the concentration of live bacteria. Results: Quantitative analysis showed no significant decrease in bacterial viability over the 12-month period for both aerobic and anaerobic cultures (p = 0.09). At all timepoints, the coefficients of variability in colony-forming unit (CFU) counts were greater between samples (102 +- 21% and 100 +- 13% for aerobic and anaerobic cultures, respectively) than the variability between measurements of the same sample (30 +- 22% and 30 +- 19%). Conclusions: The study confirmed that faecal microbiota can be preserved with high viability in deep-freeze storage for up to a year, making allogenic FMT from biobanked samples a viable and safer option for patients. However, a multidonor approach may be beneficial to mitigate the risk of viability loss in any single donor sample.
Název v anglickém jazyce
Assessment of Faecal Microbiota Transplant Stability in Deep-Freeze Conditions: A 12-Month Ex Vivo Viability Analysis
Popis výsledku anglicky
Background: Faecal microbiota transplantation (FMT) is an established treatment for Clostridioides difficile infection and is under investigation for other conditions. The availability of suitable donors and the logistics of fresh stool preparation present challenges, making frozen, biobanked stools an attractive alternative. Aims: This study aimed to evaluate the long-term viability of bacterial populations in faecal samples stored at -80oC for up to 12 months, supporting the feasibility of using frozen grafts for FMT. Methods: Fifteen faecal samples from nine healthy donors were processed, mixed with cryoprotectants and stored at -80oC. Samples were assessed at baseline and after 3, 6 and 12 months using quantitative culturing methods to determine the concentration of live bacteria. Results: Quantitative analysis showed no significant decrease in bacterial viability over the 12-month period for both aerobic and anaerobic cultures (p = 0.09). At all timepoints, the coefficients of variability in colony-forming unit (CFU) counts were greater between samples (102 +- 21% and 100 +- 13% for aerobic and anaerobic cultures, respectively) than the variability between measurements of the same sample (30 +- 22% and 30 +- 19%). Conclusions: The study confirmed that faecal microbiota can be preserved with high viability in deep-freeze storage for up to a year, making allogenic FMT from biobanked samples a viable and safer option for patients. However, a multidonor approach may be beneficial to mitigate the risk of viability loss in any single donor sample.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30221 - Critical care medicine and Emergency medicine
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Clinical Laboratory Analysis
ISSN
0887-8013
e-ISSN
1098-2825
Svazek periodika
38
Číslo periodika v rámci svazku
7
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
5
Strana od-do
"e25023"
Kód UT WoS článku
001191997800001
EID výsledku v databázi Scopus
2-s2.0-85189533145